Atai Life Sciences N.V.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Atai Life Sciences N.V.'s past years’ income statements indicate that its last revenue has increased compared to the previous period by 35% to $314,000. The net income raised on -$40,224,000 and profit margin reached -12810%. Total operating expenses were $125,785,000.

Profit Margin

Atai Life Sciences N.V. (NASDAQ:ATAI): Profit margin
2019 0 -17.47M
2020 0 -102.11M
2021 20.37M -132.61M -650.82%
2022 233K -141.41M -60691.42%
2023 314K -40.22M -12810.19%

ATAI Income Statement (2019 – 2023)

2023 2022 2021 2020 2019
Revenue
Revenue
314K233K20.37M00
Cost of revenue
0168K47K24K6K
Gross profit
314K65K20.32M-24K-6K
Operating exp.
Research and development
62.20M74.31M47.95M11.40M3.08M
Selling and marketing
00000
Total operating expenses
125.78M144.66M140.70M92.14M8.17M
Operating income
-125.47M-144.78M-135.80M-104.16M1.57M
Other income (expenses), net
86.18M9.60M-796K-74.15M-19.04M
Income before tax
-39.28M-135.18M-136.60M-101.81M-17.47M
Income tax expense
1.01M6.22M-3.98M305K2K
Net income
-40.22M-141.41M-132.61M-102.11M-17.47M
Earnings per share
Basic EPS
-0.25-0.91-0.83-17.57-3.23
Diluted EPS
-0.25-0.91-0.83-17.57-3.23
Data sourceData sourceData source